Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TRANS GENIC expects extraordinary loss for FY 2014 and lowers consolidated full-year outlook for FY 2014


Thursday, 20 Mar 2014 02:15am EDT 

TRANS GENIC INC:Expects an extraordinary loss of 34 million yen due to depletion of assets, for the fiscal year ending March 2014.Says the company lowered the consolidated full-year outlook for revenue to 1,630 million yen from 1,900 million yen for the fiscal year ended March 2014.Sees a decrease of operating profit forecast to a loss of 90 million yen from 70 million yen.Sees a decrease of ordinary profit forecast to a loss of 130 million yen from 30 million yen.Sees a decrease of net profit forecast to a loss of 120 million yen from 10 million yen.Sees a decrease of earnings per share to a loss of 8.86 yen from 0.74 yen.Comments the less-than-expected order and sales are the main reasons for the forecast. 

Company Quote

451.0
-8.0 -1.74%
2:00am EDT